H.C. Wainwright initiated coverage of Geron (GERN) with a Buy rating and $8 price target The analyst believes Rytelo is off to a strong launch. The firm expects the Rytelo launch to significantly pick up pace in 2025 with several noteworthy upcoming catalysts.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GERN:
- GERN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Disney initiated, Cisco upgraded: Wall Street’s top analyst calls
- Geron initiated with an Outperform at Scotiabank
- Longboard Pharmaceuticals downgraded to Neutral from Buy at B. Riley
- Geron gets permanent J-code for Rytelo from CMS, says Goldman Sachs